Form D · Biotechnology
Brighton Biotech, Inc.
Fort Worth, TX · CIK 0001625381
Offering snapshot reported Jun 1, 2015 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 26, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 1, 2015 | Initial | $0 | No comparison | 3 | SEC filing |
| Nov 18, 2014 | Amendment | $1,600,000 | $0vs Nov 18, 2014 | 20 | SEC filing |
| Nov 18, 2014 | Initial | $1,600,000 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-240896
Tax-free reorganization. See Item 10.
Source: Form D, filed Jun 1, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ashley Bush | Executive |
| Halden Conner | Director, Executive |
| Halden Connor | Director |
| Jeffrey A. Gelfand | Director |
| Kevin Howard Hershberger | Director, Executive |
| Jurij Petrin | Director |
| Craig Rosenfeld | Executive |
| Francis J West | Director |
| Frances West | Director |
| John White | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Fort Worth Club Bldg. 306 W. 7 Th Street, Suite 860
Fort Worth, TX, 76102
Fort Worth, TX, 76102